local anesthetic effect of Dexmedetomidine.
Conditions
Interventions
Intervention 1: Control group: 20 ml of ROPIVACAINA 0.5%, (made by Molteni company Italia) is prepared with the help of a neurse of anesthesiology according to the patient's grouping, and the surg
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients who have the consent to participate in the study Patients who are candidates for open kidney surgery
Exclusion criteria
Exclusion criteria: History of allergies to the drugs used History of addiction to drugs or other psychotropic substances History of psychological disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total analgesics consumption during the first 24 hr after surgery. Timepoint: One time at the end of the first 24 hours after operation. Method of measurement: According to the patient file and nursing report.;When was the first need for analgesics. Timepoint: During 6 hours after surgery. Method of measurement: In terms of time per minute, and according to the first time after extubation of patients, the analgesic is injected.;Acute Postoperative Pain. Timepoint: In recovery room and 1,6,12,18 and 24 hours after surgery. Method of measurement: Visual Analog Scale(VAS score).;Agitation and Sedation degree. Timepoint: In recovery room and 1,6,12,18 and 24 hours after surgery. Method of measurement: Ramsy Sedation Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadreza Khajavi
Tehran University of Medical Sciences
Outcome results
None listed